WWW.PHARMAORG.COM WWW.PHARMAORG.COM: Any drug you wish to know about

COLCHICINE       

      Colchicine is used to treat attacks of gout.

How Taken
Take each dose of Colchicine with a full glass of water. You may take this medicine up to once every hour until the pain is relieved, until the maximum amount of medicine has been taken, or until nausea, vomiting, or diarrhea occurs. To prevent an attack from occurring, you may take Colchicine every day or several days a week. Do not take more doses than your doctor prescribed.

Warnings/Precautions
Do not take Colchicine without first talking to your doctor if you are breast-feeding a baby. Talk to your doctor if you are or plan on becoming pregnant as this medicine may have harmful effects on the unborn baby.

Missed Dose
If you miss a dose, use it as soon as you remember. If it is near the time for the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.

Possible Side Effects
Some of the side effects that may occur while taking Colchicine include: difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; fever; rash; numbness or tingling.
Searching for something else? No problem!

Search for anything:

Implanted Nerve Stimulator Eases Epilepsy in Kids.
         Stimulation of a cranial nerve through an implant can effectively treat some children with epilepsy, according to the results of a new two-year study. In a study of more than 75 young patients, doctors found that 59 percent of those implanted with a vagus nerve stimulator did not suffer from localization-related epilepsy, or seizures occurring in one part of the brain. Hospital visits for epilepsy-related conditions also decreased by 41 percent, the researchers reported Wednesday at the International League Against Epilepsy Congress in Paris. The nerve stimulator is implanted in the left side of a patient's neck and works by sending signals to the brain to decrease the electrical activity that leads to seizures. It was approved by the U.S. Food and Drug Administration in 1997 for the treatment of epilepsy unresponsive to medication.
Main Page  Site Map